Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Commercial
Pricing
Pricing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pricing
Utah lawmakers advance bill targeting insulin costs ...
Firstwordpharma News
-
February 21, 2020
Pricing
Utah lawmakers advance bill targeting insulin costs ...
Pricing
People often skip neurological meds when out-of-pocket costs rise ...
Pricing
Paracetamol prices up 40% as coronavirus shuts China ...
Pricing
EO imposes price cap on 133 medicines ...
Pricing
Despite Calls to Lower Drug Prices, More than 600 Medications Saw...
Biospace News
-
February 7, 2020
0
Pricing
Medicare Could Save Billions If Allowed to Negotiate Insulin Prices ...
Firstwordpharma News
-
February 4, 2020
0
Pricing
XORTX Announces Re-Pricing of Private Placement
Firstwordpharma News
-
February 2, 2020
0
Pricing
Eli Lilly prices migraine therapy at $640 for pack of 8...
Firstwordpharma News
-
January 31, 2020
0
Pricing
Biocon plans to halve insulin prices ...
Firstwordpharma News
-
January 17, 2020
0
1
2
3
...
12
Page 1 of 12
- Advertisement -
MOST POPULAR
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit...
February 13, 2020
Bristol-Myers and Celgene’s Liso-Cel Hits Mark in Multiple Cancer Studies
December 9, 2019
Polyphor to present data on murepavadin and its lead preclinical compound...
April 4, 2019
Pfizer and Lilly’s Non-Opioid Painkiller Shows Mixed Results in Phase III
April 19, 2019
Load more
HOT NEWS
Commercial
Less Than a Year After FDA Approval, Verastem Oncology CEO Steps...
Commercial
Pharming Group announces Notice to Convene to Annual General Meeting of...
Deals
Alexion and Caelum Biosciences Announce Collaboration to Develop Targeted Therapy for...
Others
Recurrence Rates Are Not Higher in Younger Women Diagnosed With Breast...
